Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mats Remberger

Clinical trials sponsored by Mats Remberger, explained in plain language.

New cell therapy takes on deadly transplant complication

Disease control Terminated

This study tested a new treatment called DSC (donor stem cells) compared to the best available standard therapy for people with severe graft-versus-host disease (GVHD) after a stem cell transplant. GVHD happens when donor immune cells attack the patient's body, and this study foc…

Phase: PHASE2 • Sponsor: Mats Remberger • Aim: Disease control

Last updated May 22, 2026 14:04 UTC